589x658px Hero Banner Adobe Stock 404751193
Thought leadership Technology Dealtracker: Q2 2025
The report also highlights outbound strategic activity and the role of technology in operational transformation.
589x658px Hero Banner Adobe Stock 299175978
Thought leadership Pharma and Healthcare Dealtracker: Q2 2025
The report captures sector-wise shifts, investor alignment with scalable and tech-integrated models, and emerging preferences in early-stage innovation.
589x658px Hero Banner Adobe Stock 293397521
Thought leadership Automotive Dealtracker: Q2 2025
This edition captures this momentum, highlighting the sector’s alignment with technology-led growth and service-oriented models.
589x658px Hero Banner Adobe Stock 361521245
Thought leadership Real Estate/REITs Dealtracker: Q2 2025
The Q2 2025 edition of #GTBharat's Real Estate/REITs Dealtracker highlights selective capital deployment, a preference for fewer but larger transactions, and a measured return of IPO and QIP activity.
589x658px Hero Banner Adobe Stock 460322183
Thought leadership Q2 Dealtracker 2025
India’s deal environment in Q2 2025 reflected a measured approach to capital deployment, shaped by sectoral realignments and selective investor participation.
Monthly Dealtracker: May 2025
Thought leadership Monthly Dealtracker: May 2025
The May 2025 edition of Dealtracker presents a detailed analysis of sector movements, investor sentiment, and strategic shifts across deal types.

News & updates

Grant Thornton Bharat Dealtracker: India Inc. sees USD 8.7 billion in deals for August amid geopolitical challenges, telecom and EV sectors shine

09 Sep 2024

According to the Grant Thornton Bharat Dealtracker, excluding IPOs and QIPs, August 2024 deal activity witnessed a significant surge, with a total of 179 deals, amounting to USD 8.7 billion, marking a 63% increase in value compared to July.


Indian dealmaking soars to new heights in Q2 2024 in last 2 years: PE activity drives surge amid strong domestic investment and sectoral growth

05 Jul 2024

According to the Grant Thornton Bharat Dealtracker, Q2 2024, Indian dealmaking witnessed an overall 501 deals, valued at USD 21.4 billion.


Grant Thornton Bharat acts as exclusive advisor to Biorad Medisys for its fundraise of up to INR 400 Crore from Kotak Strategic Situations India Fund II

16 May 2024

Grant Thornton Bharat acts as exclusive advisor to Biorad Medisys for its fundraise of up to INR 400 Crore from Kotak Strategic Situations India Fund II